Now is a good time to circle back to something I originally posted in January 2021
In this article titled “2021: The Year of Positive CBD Policy Changes,” Jonathan Havens predicted “it seems that the White House could clear the enforcement policy sometime this year, perhaps mid-second quarter.”
Today’s Validcare news that CBD is safe for the liver at typical OTC doses would seem to clear the area for landing of FDA’s CBD Enforcement Discretion Policy in his estimated timetable
Here is the final sentence in this article:
The confluence of the release of FDA’s CBD enforcement policy and the reintroduction of legislation to permit CBD as a dietary ingredient could mean that the framework for a national uniform CBD policy standard could be in hand by this summer.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.